Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk |
Metformin, Placebo |
NCT02028221 |
Active, not recruiting |
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy |
Telapristone Acetate, Placebo, Laboratory Biomarker Analysis, Questionnaire Administration |
NCT02314156 |
Active, not recruiting |
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... |
Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine |
NCT02568566 |
Active, not recruiting |
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... |
Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery, Placebo Administration |
NCT02598557 |
Active, not recruiting |
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer |
Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim, Surgical Procedure |
NCT02636582 |
Active, not recruiting |
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive,... |
Laboratory Biomarker Analysis, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine, Sargramostim |
NCT02780401 |
Active, not recruiting |
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer |
Retinoid 9cUAB30, Therapeutic Conventional Surgery |
NCT02876640 |
Recruiting |
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to... |
Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate |
NCT02993159 |
Recruiting |
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients |
Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine |
NCT03036930 |
Active, not recruiting |
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast |
Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration |
NCT03063619 |
Recruiting |